Recent Advances in Clinical Trials

Recent Advances in Clinical Trials

Open Access
ISSN: 2771-9057
Research Article

Possible Treatments for COVID Vaccine Induced Prion Disease

Authors: Bart Classen J.

DOI: 10.33425/2771-9057.1024


Abstract

Many COVID-19 “vaccines" are considered bioweapons and are known to have the ability to cause prion disease. Prion inducing agents have been researched extensively as potential bioweapons and the field of prion research is infiltrated by clandestine bioweapons operatives. In order for prion disease inducers to be an ideal bioweapon the target population needs to believe there is no cure while the attacker knows of an treatment/ antidote to save its own population if there is “blowback”, where the attackers' population gets exposed to the bioweapon. The narrative in the prion field is that there is no effective treatment for prion disease. However false narratives are the norm in the current COVID-19 related bioweapons attack. The author performed a literature search to determine if any effective treatments to COVID “vaccine" induced prion disease may exist but hidden from the public. The author believes several such candidates may exist and their use for treating COVID “vaccine" induced prion disease needs to be explored. These agents include doxycycline and related minocycline, quinacrine and ivermectin. The nature of this paper is speculative in large part because of the use of bioweapons in the current civil war. It is of no surprise to many that people working in government, medicine, science, and the pharmaceutical industry are deliberately trying to cause harm while pretending to help humanity. One only has to read the long list of influential people associated with Mossad operative Jeffrey Epstein to realize the extent of evil in today’s world.

View / Download PDF
Citation: Bart Classen J. Possible Treatments for COVID Vaccine Induced Prion Disease. 2023; 3(2). DOI: 10.33425/2771-9057.1024
Editor-in-Chief
Mike Robinson
Mike Robinson
Medical Department | Global Cannabinoid Research Center

View full editorial board →
Journal Metrics
Impact Factor 2.9*
Acceptance Rate 80%
Time to first decision 5-8 Days
Submission to acceptance 12-15 Days